Asthma genetics study to find better treatments
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study looks at how your genes affect your asthma medications. It tests if knowing your DNA can help predict which treatment works best for you and why.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be willing to follow all study steps and be available for the whole study.
- Your asthma medications must be stable for at least 2 months, including a medium or high dose inhaled steroid and another daily controller medication.
- Your asthma must be not well-controlled or poorly controlled right now.
- You must have medical proof that your asthma is reversible, such as a positive response to a rescue inhaler or a methacholine challenge test.
- You should not be taking an asthma biologic or have stopped one within the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if the medicine Dupilumab can help control asthma and wheezing in children ages 2 to just under 6. It is for children whose symptoms are not well-managed with their current inhaler.
This study tests a new way to monitor severe asthma that is driven by high levels of inflammation (T2-high). It involves a bronchoscopy (a thin tube to look inside your lungs) to see how well the treatment is working.
This study looks at how genes are linked to different types and severities of asthma. It aims to understand why asthma affects people differently, which could lead to better treatments.
This trial looks at how certain proteins (Transgelin-2, Metallothionein-2, and Ezrin) are associated with asthma. It may help researchers better understand asthma biology and potentially guide future treatments.
This trial tests whether dupilumab can help people with moderate-to-severe asthma achieve clinical remission. It may be an option if you have asthma with high levels of certain inflammatory markers and have had at least one asthma attack in the last 2 years.
This study looks at how well different biologic treatments work for people with severe or mild-to-moderate asthma, and compares them to healthy volunteers. It aims to find which treatments work best for different asthma types.
Hear when a new Moderate to Severe Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.